WASHINGTON D.C. – Today, U.S. Senator Elissa Slotkin joined her colleagues in urging President Donald Trump to rescind his March 27 executive order to end collective bargaining agreements between public employee unions and dozens of federal agencies and bureaus.   “We write today in outrage over your recent executive order entitled Exclusions from Federal Labor-Management Relations Programs, a gross overreach of the authority granted in the Civil Service Reform Act of 1978 (CSRA). This order is an insult to the hardworking public servants who go to work on behalf of the American people,” the Senators began.  “The executive order effectively classifies two thirds of the

Washington, D.C. – U.S. Senator Elissa Slotkin (D-MI) released the following statement regarding President Trump’s reciprocal tariffs:  “The true impact of the tariffs President Trump announced today on Michigan’s economy will take weeks to assess. And that’s before each of the dozens of nations retaliates with new tariffs of their own.  “Tariffs only work when they’re used strategically. This chaotic approach to American trade policy, and the clear effects on American supply chains, at first blush appear to fail that test.  “America needs a 21st century trade policy that strengthens the Middle Class, expands American industry and jobs, provides certainty to American businesses and

WASHINGTON, D.C. – U.S. Senators Elissa Slotkin (D-MI), Catherine Cortez Masto (D-NV) and Amy Klobuchar (D-MN) introduced the Lower Drug Costs for Families Act to make prescription drugs more affordable, hold Big Pharma accountable, and reduce the national deficit by billions of dollars.    The Senators’ bill would do so by penalizing drug companies for raising prescription drug prices in the commercial market faster than the rate of inflation. I also co-led similar legislation in the House last Congress.    This legislation builds on the Inflation Reduction Act’s work to lower health costs for seniors with Medicare by ensuring that all Michiganders are protected from outrageous increases in prescription drug